Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study

ConclusionsAbatacept initiation as earlier vs later line of therapy in RA may achieve higher 2-year retention rates. RF and anti-CCP seropositivity could predict increased abatacept retention, irrespective of treatment line.Trial registrationNCT02109666

http://link.springer.com/10.1007/s10067-019-04449-w

Source: Clinical Rheumatology - February 21, 2019 Category: Rheumatology Source Type: research